Long Term Predictors of Post-Partum Glucose Metabolism in Women with Gestational Diabetes Mellitus

Abstract

Aims: The question asked by this study was whether β-cell function expressed by insulin secretion/sensitivity measured during pregnancy in women with gestational diabetes (GDM) predicts post-partum long-term derangement in glucose metabolism.

Methods: Seventy-four Caucasian women with previous GDM were retested through a 75 g-2-h-OGTT after 8 [6] years (median[interquartile range]) from index pregnancy, measuring at pregnancy and follow-up insulin sensitivity, insulin secretion (1-h-incremental-insulin-area/incremental-glucose-area: ΔAUC60_I/ΔAUC60_G) as well as the product of Stumvoll-first-phase – secretion x insulin sensitivity (insulin-secretion-sensitivity index (ISSI).

Results: At follow-up 47 women were normotelerant to glucose and 27 had altered glucose metabolism (AGM:10 with type 2 diabetes and 17 with IGT). Women progressed to AGM had at their index pregnancy higher mean 2-h-OGTT-glucose area (1.15±0.09vs. 1.09±0.09 mol l 2-h⁻¹;p=0.014), and lower ΔAUC60_I/ΔAUC60 (median [interquantile range]) (54.4 [51.7] vs. 73.4 [60] pmol mmol⁻¹) and ISSI (2 977 [766] vs. 3 708 [1 141]; p<0.05 for both), but similar insulin sensitivity index 2.9 [2.5]vs. 3.2 [2.2] ml min⁻¹ m⁻²;p=NS). Two-h-OGTT-glucose area, or decrease in ΔAUC60_I/ΔAUC60_G and ISSI were significantly associated with glucose tolerance impairment and with raised adjusted risk for AGM while insulin sensitivity at pregnancy did no predict AGM development.

Conclusions: In this group of women increased post-load plasma glucose and impaired β-cell function assessed during GDM pregnancy predict long-term post-partum AGM, while insulin sensitivity measured at the same time does not.

gestational diabetes mellitus - post-partum altered glucose metabolism - OGTT - insulin secretion - insulin sensitivity - insulin-secretion-sensitivity index

References

• 1 Ahrén B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.  Eur J Endocrinol. 2004;  150 97-104
• 2 Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes.  Diabet Med. 2004;  21 103-113
• 3 Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes.  J Clin Endocrinol Metab. 2001;  86 989-993
• 4 Buchanan TA, Catalano PM. The pathogenesis of GDM: implications for diabetes after pregnancy.  Diabetes Rev. 1995;  4 584-601
• 5 Buchanan TA, Xiang TA. Gestational diabetes mellitus.  J Clin Invest. 2005;  115 485-491
• 6 Buchanan TA, Xiang AH, Trigo E. et al . Antepartum predictors of the development of type 2 diabetes in Latino women 11–26 months after pregnancies complicated by gestational diabetes.  Diabetes. 1999;  48 2430-2436
• 7 Carpenter MW, Coustan DR. Criteria for screening test for gestational diabetes.  Am J Obstet Gynecol. 1982;  157 758-763
• 8 Carr DB, Newton KM, Utzschneider KM. et al . Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes.  Diabetes Care. 2008;  31 1037-1039
• 9 Chan SP, Gelding SV, McManus RJ. et al . Abnormalities of intermediary metabolism following a gestational diabetic pregnancy.  Clin. Endocrinol (Oxf). 1992;  36 417-420
• 10 Catalano PM, Kirwan JP, Haugel-de-Mouzon S. et al . Gestational diabetes and insulin resistance: role in short- and long term implications for mother and fetus.  J Nutr. 2003;  133 1674S-1683S
• 11 Corrado F, D'Anna R, Cannata M. et al . Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance.  Am J Obstet Gynecol. 2007;  196 e1-e5
• 12 Di Cianni G, Seghieri G, Lencioni C. et al . Normal glucose tolerance and gestational diabetes mellitus: what is in between?.  Diabetes Care. 2007;  30 1783-1788
• 13 Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal.  Diabetologia. 2004;  47 943-956
• 14 Homko C, Sivan E, Chen X. et al . Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus.  J Clin Endocrinol Metab. 2001;  86 568-573
• 15 Kautzky-Willer A, Prager R, Waldhausl W. et al . Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.  Diabetes Care. 1997;  20 1717-1723
• 16 Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes.  Diabetes Care. 2002;  25 1862-1868
• 17 Kirwan JP, Huston-Presley L, Kalhan SC. et al . Clinically useful estimates of insulin sensitivity during pregnancy.  Diabetes Care. 2001;  24 1602-1607
• 18 Kjos SL, Buchanan TA, Greenspoon JS. et al . Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum.  Am J Obstet Gynecol. 1990;  163 93-98
• 19 Kousta E, Lawrence NJ, Godsland IF. et al . Insulin resistance and b-cell dysfunction in normoglycaemic European women with a history of gestational diabetes.  Clin Endocrinol (Oxf). 2003;  59 289-297
• 20 Lencioni C, Volpe L, Miccoli R. et al . Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes.  Nutr Metab Cardiovasc Dis. 2006;  16 485-493
• 21 Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.  Diabetes Care. 1999;  22 1462-1470
• 22 Pallardo F, Herranz L, Garcia-Ingelmo T. et al . The postpartum metabolic outcome of women with previous gestational diabetes.  Diabetes Care. 1999;  22 1053-1058
• 23 Retnakaran R, Hanley AJ, Raif N. et al . Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.  Diabetologia;. 2005;  48 993-1001
• 24 Retnakaran R, Qi Y, Sermer M. et al . The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum pre-diabetes or diabetes: Implications for the diagnostic criteria for gestational diabetes.  J Clin Endocrinol Metab. 2009;  94 840-845
• 25 Ryan EA, Imes SH, Liu D. et al . Defects in insulin secretion and action in women with a history of gestational diabetes.  Diabetes. 1995;  44 506-512
• 26 Seghieri G, Tesi F, Anichini R. et al . Influence of gestational diabetes on the long-term control of glucose tolerance.  Diabetologia. 2007;  50 2234-2238 S
• 27 Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?.  Ann Intern Med. 2002;  136 575-581
• 28 Stumvoll M, Van Haeften T, Fritsche A. et al . Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times.  Diabetes Care. 2001;  24 796-797
• 29 Tai ES, Goh SY, Lee JJ. et al . Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease.  Diabetes Care. 2004;  27 1728-1734
• 30 Tirosh A, Shai I, Tekes-Manova D. et al . Normal fasting plasma glucose levels and type 2 diabetes in young men.  N Engl J Med. 2005;  353 1454-1462
• 31 Ward WK, Johnston CLW, Beard JC. et al . Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes.  1985;  34 861-869
• 32 Weijers RN, Bekedam DJ, Goldschmidt HM. et al . The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus.  Clin Chem Lab Med. 2006;  44 99-104
• 33 Xiang AH, Wang C, Peters RK. et al . Coordinate changes in plasma glucose and pancreatic β-cell function in latino women at high risk for Type 2 diabetes.  Diabetes. 2006;  55 1074-1079

Correspondence